We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $9.4M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more call options, than puts

Call options by funds: $108K | Put options by funds: $30K

33% less funds holding

Funds holding: 3 → 2 (-1)

35% less capital invested

Capital invested by funds: $14.5M → $9.4M (-$5.09M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
$108K
Puts
$30K
Net Calls
+$78K
Net Calls Change
+$60K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HVC
Healthcare Value Capital
New Jersey
-$1.43M
2
SM
Sabby Management
Florida
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$6.46M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.43M – – –
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$256K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$253K – – –
HVC
5
Healthcare Value Capital
New Jersey
$139K -$1.43M -1 Closed
BFA
6
BlackRock Fund Advisors
California
$133K – – –
Franklin Resources
7
Franklin Resources
California
$109K – – –
Northern Trust
8
Northern Trust
Illinois
$87K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$71K – – –
BIT
10
BlackRock Institutional Trust
California
$58K – – –
CC
11
Callan Capital
California
$55K – – –
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$51K – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$48K – – –
LPL Financial
14
LPL Financial
California
$36K – – –
Group One Trading
15
Group One Trading
Illinois
$33K – – –
Bank of America
16
Bank of America
North Carolina
$28K – – –
Creative Planning
17
Creative Planning
Kansas
$27K – – –
MBA
18
McQueen Ball & Associates
Pennsylvania
$25K – – –
Goldman Sachs
19
Goldman Sachs
New York
$15K – – –
BA
20
BlackRock Advisors
Delaware
$12K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$12K – – –
FANJ
22
Financial Architects (New Jersey)
New Jersey
$10K – – –
State Street
23
State Street
Massachusetts
$10K – – –
Wells Fargo
24
Wells Fargo
California
$10K – – –
BIM
25
BlackRock Investment Management
Delaware
$9K – – –
1
2

SEEL Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q4 2015, worth a combined $9.4M — down 35% from $14.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SEEL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Healthcare Value Capital, exiting entirely with an estimated $1.43M sold.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q4 2015, down from 3 in Q3 2015.
  • Funds reported $9.4M of Seelos Therapeutics, Inc. Common Stock stock for Q4 2015, down 35% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q4 2015 and 1 closed out, a net change of -1 holder.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q4 2015 was Healthcare Value Capital, an estimated $1.43M sold.

Based on aggregated 13F filings for Q4 2015.